China poised to accept non-animal test method for cosmetics
by
LAAR
China poised to accept its first ever non-animal test method
for cosmetics by late summer
"China may be quicker than the West to accept non-animal testing
alternative," says industry expert
With China poised to accept
its first ever non-animal test method for cosmetics by late summer, Dr.
Brian Jones of the Institute for In Vitro Sciences (IIVS) says don’t be
surprised by how quickly the autorities accept and implement more.
http://www.cosmeticsdesign.com/Regulation-Safety/China-may-be-quicker-than-the-West-to-accept-non-animal-testing-alternative-says-industry-expert
_______________________________________________
Recognizing the
urgent need to drive regulatory change in those countries that still require
animal testing for cosmetic and personal care products, the Institute for In
Vitro Sciences, Inc (IIVS) is expanding
its international outreach program. The expanded program will be designed to
demonstrate to regulators and industry in these countries how alternative
testing strategies for cosmetic products can be integrated into a regulatory
acceptance program.
“Generous support from industry and animal
protection organizations now enables us to expand our international programs
so we can have an impact in countries such as China, Brazil and Russia,”
said Dr. Rodger Curren, President of IIVS. He went on to announce that the
International Outreach Program will be headed by Dr. Brian Jones who has
recently joined IIVS as Director, Education and Outreach.
“We are
delighted that Dr. Brian Jones has joined our team and accepted the
challenge of leading this program,” said Dr. Curren. “Brian’s recent work
with the Chinese sFDA on alternative testing programs and his knowledge from
an industry perspective provide the experience we need to develop effective
programs of education and skills training for these geographies.”
Dr.
Jones began his career in in vitro sciences in 1984 working with Professor
Paul Kitos at the University of Kansas. He moved into the industry and
continued to work on development of non-animal methods at Mary Kay Inc.
Brian’s responsibilities included the assessment of toxicity and
sensitization potential of cosmetic ingredients and formulations. Brian left
Mary Kay to work for Cosmair, known today as L’Oreal USA, as Manager of
Toxicology and Clinical Research, including an emphasis in utilizing
alternative testing parameters for US-based products. Following Cosmair,
Brian joined Avon Products in 1998 and was responsible for re-establishing
Avon’s presence in Alternatives. Brian developed the Cell Biology and In
Vitro Laboratory which focuses on use of non-animal methods to assess the
safety and efficacy of cosmetic ingredients and products. During that time,
Brian worked with IIVS to assist Avon in being the first company to have an
insect repellent accepted by the EPA without new animal data being
generated.
In 2005, Brian returned to Mary Kay with a primary focus
on developing Mary Kay’s efficacy and safety testing using non-animal
methods. He traveled to China frequently to work with various Chinese
agencies in the area of Alternatives. These efforts included the first
conference with AQSIQ (China import/export), presentations to Chinese
dermatology associations regarding Alternatives for assessment of cosmetic
safety, and initial discussions with the Chinese sFDA regarding acceptance
of Alternatives. Brian, Mary Kay, and IIVS hosted a workshop in January 2009
with technical scientists from China CDCs and AQSIQs in the area of
Alternatives. Brian continued to establish strong contacts in the research,
government, and dermatology arenas in China to promote non-animal test
methods.
About IIVS
IIVS is
a non-profit organization operating as a center of excellence for in vitro
(non-animal) methods used for product safety testing purposes. IIVS’s
knowledge of the science and application of alternatives to animal
experiments is recognized by regulatory agencies worldwide. It provides
education and training for chemical and personal care product companies
internationally, enabling them to successfully apply non-animal methods
within their product testing programs. IIVS also performs testing services
in their own quality controlled laboratories providing access to their
expert scientific team on a contract basis.
Founded in 1997, IIVS is
recognized as a leading provider of in vitro testing in support of
toxicological safety evaluations. Rigorous scientific programs coupled with
educational and outreach initiatives have established IIVS as a global
leader in the advancement of alternatives to animal testing.
LAAR | July 25, 2012 at 8:59 am | Categories:
Animal Testing |
URL: http://wp.me/p6ERA-GS
Comment
